Request a copy

Full Text

• Goodhand J., Hedin C.R., Croft N.M. et al. Adolescents with IBD: the importance of structured transition care. Journal of Crohn's & colitis, 2011, 5: 509-519.
• Escher J.C. Transition from pediatric to adult health care in inflammatory bowel disease. Digestive diseases (Basel, Switzerland), 2009, 27: 382-386.
• Leung Y., Heyman M.B., Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist. Inflammatory bowel diseases, 2011, 17: 2169-2173.
• Van Limbergen J., Russell R.K., Drummond H.E. et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology, 2008, 135: 1114-1122.
• Escher J. Diagnostic work-up and diseaes phenotype in pediatric IBD: 2 year results from the ESPGHAN registry. J. Pediatr. Gastroenterol. Nutr., 2006, 43: S8-10.
• Hyams J., Crandall W., Kugathasan S. et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology, 2007, 132: 863-873; quiz 1165-1166.
• Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane database of systematic reviews (Online). 2001: CD000542.
• Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J. Pediatr. Gastroenterol. Nutr., 2005, 41: 1-7.
• Hummel T.Z., ten Kate F.J., Reitsma J.B. et al. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J. Pediatr. Gastroenterol. Nutr., 2012, 54: 753-757.
• Kovacs M., Muller K.E., Arato A. et al. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. Journal of Crohn's & colitis, 2012, 6: 86-94.
• De Greef E., Mahachie John J.M., Hoffman I. et al. Profile of pediatric Crohn's disease in Belgium. Journal of Crohn's & colitis, 2013.
• Hyams J.S., Ferry G.D., Mandel F.S. et al. Development and validation of a pediatric Crohn's disease activity index. J. Pediatr. Gastroenterol. Nutr., 1991, 12: 439-447.
• Silverberg M.S., Satsangi J., Ahmad T. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2005, 19 Suppl A: 5-36.
• Levine A., Griffiths A., Markowitz J. et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflammatory bowel diseases, 2011, 17: 1314-1321.
• De Greef E., Hoffman I., Smets F. et al. Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features. Gastroenterology, 2011, 140: S789.
• Bousvaros A., Antonioli D.A., Colletti R.B. et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J. Pediatr. Gastroenterol. Nutr., 2007, 44: 653-674.
• Biancone L., Michetti P., Travis S. et al. European evidence-based Consensus on the management of ulcerative colitis: Special situations. Journal of Crohn's & colitis, 2008, 2: 63-92.
• de Bie C.I., Buderus S., Sandhu B.K. et al. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the EUROKIDS registry. J. Pediatr. Gastroenterol. Nutr., 2012, 54: 374-380.
• Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane database of systematic reviews (Online). 2007: CD000542.
• Lim W.C., Hanauer S. Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane database of systematic reviews (Online). 2010: CD008870.